Subscription: Value Stocks
EXEL - great long term bullish pattern for a profitable biopharma treating cancer
Exelixis, Inc. is a bio pharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer.
EXEL has been following a textbook Five Wave up fractal. I have been watching that company for months. Off the top of wave ( 3 ) up reached at 32.50 on Oct 16th, 2017 it played a nice pullback in wave ( 4 ) down shaped as (A)-(B)-(C). Off that lo made at 13.42 on October 2018 we should get wave ( 5 ) up structured as ( A ) up – ( B ) down – ( C ) up. The final wave ( C ) up should break out over the top seen in 2017 and make a new all time high for this stock.
EXEL - Daily chart updated on 6-19-19
Financial Strength
The company is very profitable with Operating Profit at 48%. And it does not have any debt. Its a cash generating machine! We can only wish they paid dividend!
Operating Margin
48
Net
Margin
76
Return on Capital
418
Price-to-Free-Cash-Flow
13.8
Debt-to-Ebitda
Dividend Yield
Trading is risky. Read this important Disclaimer
HIGH RISK WARNING
Trading stocks, options, or futures carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. CastAway Trader LLC provides general overview of trading methods that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future profits.